Loading chat...
AZ SB1453
Bill
Status
2/1/2023
Primary Sponsor
Thomas Shope
Click for details
AI Summary
-
Prohibits processing, manufacturing, distributing, or selling hemp-derived manufactured impairing cannabinoids in Arizona except through licensed nonprofit medical marijuana dispensaries or marijuana establishments with Department of Health Services approval.
-
Defines "hemp-derived manufactured impairing cannabinoids" to include delta-8 THC, delta-9 THC over 0.3%, delta-10 THC, hexahydrocannabinol, tetrahydrocannabiphorol, and related synthetic cannabinoids derived from chemically converting naturally occurring hemp cannabinoids.
-
Requires Department of Health Services to adopt regulations governing processing, manufacturing, and sale of these products, including labeling that states "this product is not marijuana" and warning requirements about health risks.
-
Establishes that violations are class 2 misdemeanors and allows private civil causes of action for damages, with funds from medical marijuana and Smart and Safe Arizona funds allocated to implementation and poison control center education.
-
Exempts the Department of Health Services from standard rulemaking procedures for 36 months and makes the chapter effective only upon affirmative vote of at least three-fourths of both legislative houses.
Legislative Description
Hemp-derived impairing cannabinoids; regulation
Prohibition
Last Action
Senate HHS Committee action: Failed To Pass, voting: (3-4-0-0)
2/14/2023